Interleukin-4 and Interleukin-13 (IL-4/13) Dual Cytokine Trap: Started Phase I

Regeneron Pharmaceuticals Inc. (REGN), Tarrytown, N.Y. Product: Interleukin-4 and Interleukin-13 (IL-4/13) Dual Cytokine Trap Business: Pulmonary Therapeutic category: Immune suppression Target: IL-4 ...